Your browser doesn't support javascript.
loading
Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization.
Friedrich, Nikolas; Stiegeler, Emanuel; Glögl, Matthias; Lemmin, Thomas; Hansen, Simon; Kadelka, Claus; Wu, Yufan; Ernst, Patrick; Maliqi, Liridona; Foulkes, Caio; Morin, Mylène; Eroglu, Mustafa; Liechti, Thomas; Ivan, Branislav; Reinberg, Thomas; Schaefer, Jonas V; Karakus, Umut; Ursprung, Stephan; Mann, Axel; Rusert, Peter; Kouyos, Roger D; Robinson, John A; Günthard, Huldrych F; Plückthun, Andreas; Trkola, Alexandra.
Afiliação
  • Friedrich N; Institute of Medical Virology, University of Zurich (UZH), Zurich, Switzerland.
  • Stiegeler E; Institute of Medical Virology, University of Zurich (UZH), Zurich, Switzerland.
  • Glögl M; Roche Diagnostics GmbH, Nonnenwald 2, 82377, Penzberg, Deutschland.
  • Lemmin T; Institute of Medical Virology, University of Zurich (UZH), Zurich, Switzerland.
  • Hansen S; Institute of Medical Virology, University of Zurich (UZH), Zurich, Switzerland.
  • Kadelka C; Department of Computer Science, ETH Zurich, Zurich, Switzerland.
  • Wu Y; Euler Institute, Faculty of Biomedicine, Università della Svizzera italiana (USI), Lugano, Switzerland.
  • Ernst P; Department of Biochemistry, University of Zurich (UZH), Zurich, Switzerland.
  • Maliqi L; NGM Bio, 333 Oysterpoint Blvd, South San Francisco, CA, 94080, USA.
  • Foulkes C; Department of Mathematics, Iowa State University, Ames, IA, USA.
  • Morin M; Department of Biochemistry, University of Zurich (UZH), Zurich, Switzerland.
  • Eroglu M; Innovent Biologics Inc, 168 Dongping Street, Suzhou Industrial Park, 215123, China.
  • Liechti T; Department of Biochemistry, University of Zurich (UZH), Zurich, Switzerland.
  • Ivan B; Office Research and Teaching, Medical Faculty, University of Zurich, Zurich, Switzerland.
  • Reinberg T; Institute of Medical Virology, University of Zurich (UZH), Zurich, Switzerland.
  • Schaefer JV; Institute of Medical Virology, University of Zurich (UZH), Zurich, Switzerland.
  • Karakus U; Department of Chemistry, University of Zurich (UZH), Zurich, Switzerland.
  • Ursprung S; BeiGene Switzerland GmbH, Aeschengraben 27, 4051, Basel, Switzerland.
  • Mann A; Institute of Medical Virology, University of Zurich (UZH), Zurich, Switzerland.
  • Rusert P; Janssen Vaccines AG, Rehhagstrasse 79, 3018, Bern, Switzerland.
  • Kouyos RD; Institute of Medical Virology, University of Zurich (UZH), Zurich, Switzerland.
  • Robinson JA; ImmunoTechnology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.
  • Günthard HF; Institute of Medical Virology, University of Zurich (UZH), Zurich, Switzerland.
  • Plückthun A; Laboratory Medicine, Division of Clinical Chemistry, University Hospital Basel, Basel, Switzerland.
  • Trkola A; Department of Biochemistry, University of Zurich (UZH), Zurich, Switzerland.
Nat Commun ; 12(1): 6705, 2021 11 18.
Article em En | MEDLINE | ID: mdl-34795280
ABSTRACT
The V3 loop of the HIV-1 envelope (Env) protein elicits a vigorous, but largely non-neutralizing antibody response directed to the V3-crown, whereas rare broadly neutralizing antibodies (bnAbs) target the V3-base. Challenging this view, we present V3-crown directed broadly neutralizing Designed Ankyrin Repeat Proteins (bnDs) matching the breadth of V3-base bnAbs. While most bnAbs target prefusion Env, V3-crown bnDs bind open Env conformations triggered by CD4 engagement. BnDs achieve breadth by focusing on highly conserved residues that are accessible in two distinct V3 conformations, one of which resembles CCR5-bound V3. We further show that these V3-crown conformations can, in principle, be attacked by antibodies. Supporting this conclusion, analysis of antibody binding activity in the Swiss 4.5 K HIV-1 cohort (n = 4,281) revealed a co-evolution of V3-crown reactivities and neutralization breadth. Our results indicate a role of V3-crown responses and its conformational preferences in bnAb development to be considered in preventive and therapeutic approaches.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Conformação Proteica / Anticorpos Anti-HIV / HIV-1 / Produtos do Gene env do Vírus da Imunodeficiência Humana / Anticorpos Neutralizantes Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Conformação Proteica / Anticorpos Anti-HIV / HIV-1 / Produtos do Gene env do Vírus da Imunodeficiência Humana / Anticorpos Neutralizantes Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça